Interstitial lung disease
Make an Appointment
Talk to DoctorOverview
Interstitial lung disease, also known as diffuse parenchymal lung disease (DPLD), encompasses a wide range of conditions, the majority of which lead to the gradual formation of scar tissue in the lungs. This scarring ultimately hampers one’s ability to breathe and impedes the intake of sufficient oxygen into the bloodstream.
Long–term exposure to harmful substances, such as asbestos, can be a catalyst for interstitial lung disease. Additionally, certain autoimmune disorders like rheumatoid arthritis may contribute to the development of this condition. Nevertheless, in some instances, the exact causes remain elusive.
It is important to note that once lung scarring occurs, it is typically irreversible. While medications can help slow down the progression of interstitial lung disease, many individuals may never fully regain their lung function. For select individuals with this condition, a lung transplant may be considered as a potential treatment option.
Symptoms
Interstitial lung disease typically presents with the following common symptoms:
- Shortness of breath, whether it occurs during rest or is exacerbated by physical exertion.
- A persistent, dry cough.
- Fatigue.
- Chest discomfort.
It’s important to be aware that when these symptoms become noticeable, irreversible lung damage may have already occurred. Therefore, seeking prompt medical attention when initial breathing difficulties arise is essential. Numerous respiratory ailments besides interstitial lung disease have the potential to impact the lungs, emphasizing the critical need to secure an early and precise diagnosis to facilitate effective treatment.
Causes
Interstitial lung disease occurs when lung injury triggers an abnormal healing response, leading to scarring and thickening of the tissue around air sacs (alveoli), making it harder for oxygen to enter the bloodstream. Causes include:
- Occupational and environmental factors: Prolonged exposure to toxins like silica dust, asbestos fibers, grain dust, animal droppings, radiation, and indoor hot tubs can harm the lungs. Radiation therapy for lung or breast cancer can also lead to lung damage.
- Medications: Certain drugs, such as chemotherapy medications, heart drugs (e.g., amiodarone, propranolol), some antibiotics, and anti–inflammatory drugs, can damage lung tissue.
- Medical conditions: Autoimmune diseases like rheumatoid arthritis, scleroderma, dermatomyositis, polymyositis, mixed connective tissue disease, Sjogren’s syndrome, and sarcoidosis can cause lung damage.
- Idiopathic interstitial pneumonias: In some cases, the cause of interstitial lung disease remains unknown, and these cases are categorized as idiopathic interstitial pneumonias, with idiopathic pulmonary fibrosis being the most common and severe form.
Risk factors
Certain factors can increase your vulnerability to interstitial lung disease, including:
- Age: Interstitial lung disease predominantly affects adults, although it can occasionally develop in infants and children.
- Occupational and environmental exposure: If you work in industries like mining, farming, or construction, or if you are regularly exposed to lung–damaging pollutants, your risk of developing interstitial lung disease is heightened.
- Gastroesophageal reflux disease (GERD): Uncontrolled acid reflux or indigestion can elevate your risk of interstitial lung disease.
- Smoking: Some variants of interstitial lung disease are more prevalent among individuals with a history of smoking. Active smoking can also exacerbate the condition, particularly if it is accompanied by emphysema.
- Radiation and chemotherapy: Undergoing radiation therapy to the chest or using specific chemotherapy medications can increase the likelihood of developing lung disease.
Diagnosis
Diagnosing and identifying the underlying causes of interstitial lung disease (ILD) can pose significant challenges due to the diverse range of disorders falling under this category. Additionally, many medical conditions can present symptoms that mimic ILD, necessitating a thorough diagnostic process to rule out other potential causes. Various tests and procedures may be required, including:
Laboratory Tests:
- Blood Tests: Specific blood tests can be employed to detect proteins, antibodies, and markers indicative of autoimmune diseases or inflammatory responses triggered by environmental exposures, such as mold or bird proteins.
Imaging Tests:
- Computerized tomography (CT) scan: High–resolution CT scans are instrumental in diagnosing ILD and are often the initial step in the diagnostic process. CT scanners generate cross–sectional images of internal structures by combining X–ray images from multiple angles. They can reveal the extent of lung damage caused by ILD and provide detailed information about fibrosis, aiding in narrowing down the diagnosis and treatment decisions.
- Echocardiogram: An echocardiogram uses sound waves to visualize the heart’s structures and function. It can assess the pressure in the right side of the heart, which can be relevant in ILD cases.
Pulmonary Function Tests:
- Spirometry and diffusion capacity: These tests involve exhaling forcefully into a tube connected to a machine that measures lung capacity and airflow. They also assess the ease with which oxygen moves from the lungs into the bloodstream.
- Oximetry: This straightforward test utilizes a small device placed on a finger to measure blood oxygen saturation. It may be conducted at rest or during activity to monitor the progression and severity of lung disease.
Lung tissue analysis: Diagnosing pulmonary fibrosis often requires the examination of a small lung tissue sample (biopsy) in a laboratory. This can be achieved through various methods:
- Bronchoscopy: During bronchoscopy, a doctor retrieves tiny tissue samples, typically no larger than a pinhead, using a flexible tube (bronchoscope) inserted through the mouth or nose into the lungs. Risks are generally minimal, with temporary sore throat and hoarseness being the most common side effects. However, the sample size may sometimes be insufficient for an accurate diagnosis.
- Bronchoalveolar lavage: This procedure involves injecting a small amount of saline solution into a lung section via a bronchoscope and immediately suctioning it out. The withdrawn solution contains cells from the air sacs. While bronchoalveolar lavage samples a larger lung area, it may not always provide enough information for a definitive diagnosis.
- Surgical biopsy: Though more invasive and carrying potential complications, surgical biopsy is often necessary to obtain a sufficiently large tissue sample for an accurate diagnosis. This procedure is conducted under general anesthesia, with surgical instruments and a small camera inserted through small incisions between the ribs. The camera allows the surgeon to view the lungs on a video monitor while collecting tissue samples.
Treatment
Interstitial lung disease (ILD) is characterized by irreversible lung scarring, and while treatment cannot always halt its progression, certain therapies can provide temporary relief and enhance the quality of life for affected individuals. For certain ILDs lacking approved treatments, participation in clinical studies may offer access to experimental therapies.
Medications
Research is ongoing to discover effective treatments for various ILDs. Based on current scientific evidence, your physician might recommend the following:
- Corticosteroid medications: Many ILD patients initially receive corticosteroids like prednisone, sometimes combined with immunosuppressive drugs. This combination may slow or stabilize disease progression, depending on its cause.
- Medications for idiopathic pulmonary fibrosis (IPF): For IPF, medications like pirfenidone (Esbriet) and nintedanib (Ofev) can potentially slow the rate of disease advancement. These drugs may have significant side effects, so discuss their pros and cons with your doctor.
- Medications to reduce stomach acid: GERD commonly affects IPF patients and can worsen lung damage. If you have acid reflux symptoms, your physician may prescribe treatments like H–2 receptor antagonists or proton pump inhibitors (e.g., lansoprazole, omeprazole, pantoprazole) to decrease stomach acid.
Oxygen Therapy: Although it cannot reverse lung damage, oxygen therapy can provide several benefits:
- Easier breathing and improved exercise capacity
- Prevention or reduction of complications resulting from low blood oxygen levels
- Lowering blood pressure in the right side of the heart
- Enhanced sleep quality and overall well–being
Oxygen therapy is often used during sleep or physical activity, but some individuals may require continuous oxygen usage.
Pulmonary rehabilitation: Pulmonary rehabilitation programs aim to enhance daily functioning and overall life satisfaction for individuals with ILD. They typically focus on:
- Physical exercise to enhance endurance
- Breathing techniques to improve lung efficiency
- Emotional support
- Nutritional counseling
Surgery
Lung transplantation may be considered as a last–resort option for severe ILD cases that have not responded to other treatments.
In summary, while interstitial lung disease poses challenges due to its irreversible nature, various therapies and interventions can help manage symptoms, slow disease progression, and improve the overall quality of life for affected individuals. Consult with your healthcare team to determine the most appropriate treatment plan based on your specific condition.
